Gordon B. Mills, M.D., Ph.D., is the Ann Rife Cox chair of gynecology, chair of the department of systems biology in the Division of Cancer Medicine and co-head of the Kleberg Center for Molecular Markers of the University of Texas M. D. Anderson Cancer Center.
Mills received his doctoral degree in biochemistry and his medical degree from the University of Alberta. In 1985, he joined the faculty of the University of Toronto where he became associate professor in the obstetrics and gynecology, immunology, and clinical biochemistry departments; he also served as director of oncology research at the Toronto Hospital. Mills joined the University of Texas M. D. Anderson Cancer Center in 1994 where he is a professor in the departments of medicine, immunology and tumor biology, as well as chair for the newly created department of systems biology. He also co-directs the Robert J. Kleberg, Jr. & Helen C. Kleberg Center for Molecular Markers.
Mills’ research focuses on the PI3K pathway, lysophospholipids, the genomics and genetics of women’s cancers, and identifying and characterizing a number of potential oncogenes and tumor suppressor genes. He holds more than 20 patents in novel technologies and molecular biomarkers, was the founding head of the M. D. Anderson Cancer Center Technology Review Committee, and has contributed more than 400 papers to Nature, Cell, Oncogene, Cancer Research and Clinical Cancer Research, among others.